{
    "nctId": "NCT05301790",
    "briefTitle": "Breast MRI in Evaluation of Pathologic Response in Patients With Breast Cancer With Neoadjuvent Chemotherapy",
    "officialTitle": "Added Value of Breast MRI in Evaluation of Pathologic Response in Patients With Locally Advanced Breast Cancer Who Undergo Neoadjuvent Chemotherapy",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Role of MRI in Evaluation of Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 45,
    "primaryOutcomeMeasure": "comparison of MRI findings with pathologic results",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* all women referred to the radiology department for breast MRI examination either for screening, evaluation of suspicious lesions onsono-mammography \\\\\n\n  * Patients with locally advanced breast cancer\n  * Patients with early stage breast cancer and chemo-responsive tumour markers (i.e. triple negative, Her2+), who will benefit from downsizing for breast conserving surgery (BCS)\n  * Absolute or Relative contraindications to surgery (advanced age/multiple medical comorbidities) in the setting of estrogen receptor positive tumours (for consideration of neoadjuvant endocrine therapy)3\n  * Patients must be elder than 18 years old.\n* patients with accepted renal function\n\nExclusion Criteria:\n\n* Patients with metastatic breast cancer.\n* Patient with breast mass more than 5 cm .\n* Patients with fungating breast mass .\n* Patients with stage IV \\[tumor spread to chest wall and to skin \\].\n* pregnant women especially in 1th trimester.\n* Patient with presence of any paramagnetic substance as pacemakers.\n* severely ill patients .\n* patients with claustrophobia.\n* arrhythmic patients",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}